A
Annette Dieing
Researcher at Charité
Publications - 25
Citations - 990
Annette Dieing is an academic researcher from Charité. The author has contributed to research in topics: Gemcitabine & Breast cancer. The author has an hindex of 12, co-authored 25 publications receiving 909 citations. Previous affiliations of Annette Dieing include Humboldt University of Berlin.
Papers
More filters
Journal ArticleDOI
European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I
Susanne Krege,Jörg Beyer,Rainer Souchon,Peter Albers,Walter Albrecht,Ferran Algaba,Michael Bamberg,István Bodrogi,Carsten Bokemeyer,Eva Cavallin-Ståhl,Johannes Classen,C Clemm,Gabriella Cohn-Cedermark,Stéphane Culine,Gedske Daugaard,Pieter H.M. De Mulder,Maria De Santis,Maike de Wit,Ronald de Wit,H. G. Derigs,Klaus Peter Dieckmann,Annette Dieing,Jean Pierre Droz,Martin Fenner,Karim Fizazi,Aude Flechon,Sophie D. Fosså,Xavier Garcia del Muro,Thomas Gauler,Lajos Géczi,Arthur Gerl,Jose Ramon Germa-Lluch,Silke Gillessen,Jörg T. Hartmann,Michael Hartmann,Axel Heidenreich,Wolfgang Hoeltl,Alan Horwich,Robert Huddart,Michael Jewett,Johnathan Joffe,William G. Jones,László Kisbenedek,Olbjørn Klepp,S. Kliesch,Kai Uwe Koehrmann,Christian K. Kollmannsberger,Markus A. Kuczyk,Pilar Laguna,Oscar Leiva Galvis,Volker Loy,Malcolm David Mason,Graham M. Mead,Rolf Mueller,Craig R. Nichols,Nicola Nicolai,Tim Oliver,D. Ondruš,Gosse O N Oosterhof,Luis Paz Ares,Giorgio Pizzocaro,Jörg Pont,Tobias Pottek,Thomas Powles,Oliver Rick,Giovanni Rosti,Roberto Salvioni,Jutta Scheiderbauer,Hans U. Schmelz,Heinz Schmidberger,Hans-Joachim Schmoll,Mark Schrader,Felix Sedlmayer,Niels E. Skakkebæk,Aslam Sohaib,Sergei Tjulandin,Padraig Warde,Stefan Weinknecht,Lothar Weissbach,Christian Wittekind,Eva Winter,Lori Wood,Hans von der Maase +82 more
TL;DR: F refinements in the treatment of early- and advanced-stage testicular cancer have emerged from clinical trials, and expert clinical skills will continue to be one of the major determinants for the prognosis of patients with germ cell cancer.
Journal ArticleDOI
High-dose chemotherapy (HDCT) as second salvage treatment in patients with multiple relapsed or refractory germ cell tumors
Jörg Beyer,M. Hackenthal,Anja Lorch,Andreas Neubauer,Annette Dieing,Oliver Rick,J. T. Hartmann,Carsten Bokemeyer +7 more
TL;DR: HDCT can induce remissions in patients with multiple relapsed GCTs with a long-term survival rate of approximately 17%, and nine patients remain alive and free of progression.
Journal ArticleDOI
High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors
Anja Lorch,Andreas Neubauer,M. Hackenthal,Annette Dieing,J. T. Hartmann,Oliver Rick,Carsten Bokemeyer,Jörg Beyer +7 more
TL;DR: In this article, the authors evaluated the long-term survival after high-dose chemotherapy (HDCT) as second-salvage treatment (SST) in multiple relapsed germ-cell tumors (GCTs).
Journal ArticleDOI
Orbital metastases in breast cancer: report of two cases and review of the literature.
Annette Dieing,Carsten-Oliver Schulz,Peter Schmid,A. C. Roever,Silvia Lehenbauer-Dehm,Christian Jehn,Bernd Flath,Kurt Possinger +7 more
TL;DR: Most eye metastases of breast cancer are located in the choroidea, while an extrabulbar localization within the orbit is rare, with only 3–10% of all ocular metastases.
Book ChapterDOI
The effect of induced hyperthermia on the immune system.
Annette Dieing,Olaf Ahlers,Bert Hildebrandt,Thoralf Kerner,Ingo Tamm,Kurt Possinger,Peter Wust +6 more
TL;DR: This chapter reviews the most relevant data known about the effect of hyperthermia on the immune system with special focus on alterations induced by therapeutical whole-body hyperThermia (WBH) in cancer patients.